Acta Pharmaceutica Sinica B-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2239955, encodeId=634c22399558e, content=这个杂志不建议投，真慢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=faf92276694, createdName=121b8024m37(暂无昵称), createdTime=Fri Nov 29 19:54:09 CST 2024, time=2024-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2149724, encodeId=9c952149e2440, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：生物;药理 经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8e7d2228833, createdName=Mr.Curiosity, createdTime=Tue Jul 25 11:41:51 CST 2023, time=2023-07-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2243080, encodeId=3029224308039, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：请问需要流式的原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ece5698328, createdName=ms2000001785238562, createdTime=Tue Dec 17 10:34:35 CST 2024, time=2024-12-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2212910, encodeId=824c2212910f4, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：自从收到预接受文件满心欢喜。修回格式已经20天了，还没有收到正式接收的邮件，心里忐忑不安。。。。有没有朋友遇到同样情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=ed509121182, createdName=科研~菜鸟, createdTime=Wed Jul 03 08:54:51 CST 2024, time=2024-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2237949, encodeId=d77a223e94955, content=偏重的研究方向：肿瘤 经验分享：请问下，投稿之后需要所有作者确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d539038449, createdName=ms8000000170261507, createdTime=Wed Nov 20 11:08:46 CST 2024, time=2024-11-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2094226, encodeId=6a6e20942265e, content=为什么他们Decision in Process也很长时间啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Mon Oct 17 15:06:43 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2231244, encodeId=0472223124429, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23228777946, createdName=ms4000000258200034, createdTime=Wed Oct 16 19:59:25 CST 2024, time=2024-10-16, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2230114, encodeId=d98a223011450, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3b29401030, createdName=ms6000002046878418, createdTime=Thu Oct 10 10:05:03 CST 2024, time=2024-10-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=568875, encodeId=d75e5688e599, content=请问后面什么情况奔跑在Nature路上的小兽医 2018-06-20 16:18:00 发表: 2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu, beContent=奔跑在Nature路上的小兽医 2018-06-20 16:18:00 发表: 2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73ea1969766, createdName=∠※∠※, createdTime=Sat Mar 30 00:00:00 CST 2019, time=2019-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566871, encodeId=8ccc5668e10f, content=投稿10多天，状态一直在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=406a1737298, createdName=成吉思汗111, createdTime=Sun Feb 17 12:25:00 CST 2019, time=2019-02-17, status=1, ipAttribution=)]

2024-11-29 121b8024m37(暂无昵称) 来自河南省

这个杂志不建议投，真慢！

14 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2239955, encodeId=634c22399558e, content=这个杂志不建议投，真慢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=faf92276694, createdName=121b8024m37(暂无昵称), createdTime=Fri Nov 29 19:54:09 CST 2024, time=2024-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2149724, encodeId=9c952149e2440, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：生物;药理 经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8e7d2228833, createdName=Mr.Curiosity, createdTime=Tue Jul 25 11:41:51 CST 2023, time=2023-07-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2243080, encodeId=3029224308039, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：请问需要流式的原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ece5698328, createdName=ms2000001785238562, createdTime=Tue Dec 17 10:34:35 CST 2024, time=2024-12-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2212910, encodeId=824c2212910f4, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：自从收到预接受文件满心欢喜。修回格式已经20天了，还没有收到正式接收的邮件，心里忐忑不安。。。。有没有朋友遇到同样情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=ed509121182, createdName=科研~菜鸟, createdTime=Wed Jul 03 08:54:51 CST 2024, time=2024-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2237949, encodeId=d77a223e94955, content=偏重的研究方向：肿瘤 经验分享：请问下，投稿之后需要所有作者确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d539038449, createdName=ms8000000170261507, createdTime=Wed Nov 20 11:08:46 CST 2024, time=2024-11-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2094226, encodeId=6a6e20942265e, content=为什么他们Decision in Process也很长时间啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Mon Oct 17 15:06:43 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2231244, encodeId=0472223124429, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23228777946, createdName=ms4000000258200034, createdTime=Wed Oct 16 19:59:25 CST 2024, time=2024-10-16, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2230114, encodeId=d98a223011450, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3b29401030, createdName=ms6000002046878418, createdTime=Thu Oct 10 10:05:03 CST 2024, time=2024-10-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=568875, encodeId=d75e5688e599, content=请问后面什么情况奔跑在Nature路上的小兽医 2018-06-20 16:18:00 发表: 2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu, beContent=奔跑在Nature路上的小兽医 2018-06-20 16:18:00 发表: 2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73ea1969766, createdName=∠※∠※, createdTime=Sat Mar 30 00:00:00 CST 2019, time=2019-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566871, encodeId=8ccc5668e10f, content=投稿10多天，状态一直在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=406a1737298, createdName=成吉思汗111, createdTime=Sun Feb 17 12:25:00 CST 2019, time=2019-02-17, status=1, ipAttribution=)]

2023-07-25 Mr.Curiosity 来自安徽省

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：生物;药理
经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久

167 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2239955, encodeId=634c22399558e, content=这个杂志不建议投，真慢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=faf92276694, createdName=121b8024m37(暂无昵称), createdTime=Fri Nov 29 19:54:09 CST 2024, time=2024-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2149724, encodeId=9c952149e2440, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：生物;药理 经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8e7d2228833, createdName=Mr.Curiosity, createdTime=Tue Jul 25 11:41:51 CST 2023, time=2023-07-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2243080, encodeId=3029224308039, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：请问需要流式的原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ece5698328, createdName=ms2000001785238562, createdTime=Tue Dec 17 10:34:35 CST 2024, time=2024-12-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2212910, encodeId=824c2212910f4, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：自从收到预接受文件满心欢喜。修回格式已经20天了，还没有收到正式接收的邮件，心里忐忑不安。。。。有没有朋友遇到同样情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=ed509121182, createdName=科研~菜鸟, createdTime=Wed Jul 03 08:54:51 CST 2024, time=2024-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2237949, encodeId=d77a223e94955, content=偏重的研究方向：肿瘤 经验分享：请问下，投稿之后需要所有作者确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d539038449, createdName=ms8000000170261507, createdTime=Wed Nov 20 11:08:46 CST 2024, time=2024-11-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2094226, encodeId=6a6e20942265e, content=为什么他们Decision in Process也很长时间啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Mon Oct 17 15:06:43 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2231244, encodeId=0472223124429, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23228777946, createdName=ms4000000258200034, createdTime=Wed Oct 16 19:59:25 CST 2024, time=2024-10-16, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2230114, encodeId=d98a223011450, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3b29401030, createdName=ms6000002046878418, createdTime=Thu Oct 10 10:05:03 CST 2024, time=2024-10-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=568875, encodeId=d75e5688e599, content=请问后面什么情况奔跑在Nature路上的小兽医 2018-06-20 16:18:00 发表: 2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu, beContent=奔跑在Nature路上的小兽医 2018-06-20 16:18:00 发表: 2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73ea1969766, createdName=∠※∠※, createdTime=Sat Mar 30 00:00:00 CST 2019, time=2019-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566871, encodeId=8ccc5668e10f, content=投稿10多天，状态一直在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=406a1737298, createdName=成吉思汗111, createdTime=Sun Feb 17 12:25:00 CST 2019, time=2019-02-17, status=1, ipAttribution=)]

2024-12-17 ms2000001785238562 来自吉林省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤学
经验分享：请问需要流式的原始数据吗？

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2239955, encodeId=634c22399558e, content=这个杂志不建议投，真慢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=faf92276694, createdName=121b8024m37(暂无昵称), createdTime=Fri Nov 29 19:54:09 CST 2024, time=2024-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2149724, encodeId=9c952149e2440, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：生物;药理 经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8e7d2228833, createdName=Mr.Curiosity, createdTime=Tue Jul 25 11:41:51 CST 2023, time=2023-07-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2243080, encodeId=3029224308039, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：请问需要流式的原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ece5698328, createdName=ms2000001785238562, createdTime=Tue Dec 17 10:34:35 CST 2024, time=2024-12-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2212910, encodeId=824c2212910f4, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：自从收到预接受文件满心欢喜。修回格式已经20天了，还没有收到正式接收的邮件，心里忐忑不安。。。。有没有朋友遇到同样情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=ed509121182, createdName=科研~菜鸟, createdTime=Wed Jul 03 08:54:51 CST 2024, time=2024-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2237949, encodeId=d77a223e94955, content=偏重的研究方向：肿瘤 经验分享：请问下，投稿之后需要所有作者确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d539038449, createdName=ms8000000170261507, createdTime=Wed Nov 20 11:08:46 CST 2024, time=2024-11-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2094226, encodeId=6a6e20942265e, content=为什么他们Decision in Process也很长时间啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Mon Oct 17 15:06:43 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2231244, encodeId=0472223124429, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23228777946, createdName=ms4000000258200034, createdTime=Wed Oct 16 19:59:25 CST 2024, time=2024-10-16, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2230114, encodeId=d98a223011450, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3b29401030, createdName=ms6000002046878418, createdTime=Thu Oct 10 10:05:03 CST 2024, time=2024-10-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=568875, encodeId=d75e5688e599, content=请问后面什么情况奔跑在Nature路上的小兽医 2018-06-20 16:18:00 发表: 2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu, beContent=奔跑在Nature路上的小兽医 2018-06-20 16:18:00 发表: 2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73ea1969766, createdName=∠※∠※, createdTime=Sat Mar 30 00:00:00 CST 2019, time=2019-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566871, encodeId=8ccc5668e10f, content=投稿10多天，状态一直在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=406a1737298, createdName=成吉思汗111, createdTime=Sun Feb 17 12:25:00 CST 2019, time=2019-02-17, status=1, ipAttribution=)]

2024-07-03 科研~菜鸟来自河南省

审稿速度:2.0
偏重的研究方向：肿瘤
经验分享：自从收到预接受文件满心欢喜。修回格式已经20天了，还没有收到正式接收的邮件，心里忐忑不安。。。。有没有朋友遇到同样情况的？

80 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2239955, encodeId=634c22399558e, content=这个杂志不建议投，真慢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=faf92276694, createdName=121b8024m37(暂无昵称), createdTime=Fri Nov 29 19:54:09 CST 2024, time=2024-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2149724, encodeId=9c952149e2440, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：生物;药理 经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8e7d2228833, createdName=Mr.Curiosity, createdTime=Tue Jul 25 11:41:51 CST 2023, time=2023-07-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2243080, encodeId=3029224308039, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：请问需要流式的原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ece5698328, createdName=ms2000001785238562, createdTime=Tue Dec 17 10:34:35 CST 2024, time=2024-12-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2212910, encodeId=824c2212910f4, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：自从收到预接受文件满心欢喜。修回格式已经20天了，还没有收到正式接收的邮件，心里忐忑不安。。。。有没有朋友遇到同样情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=ed509121182, createdName=科研~菜鸟, createdTime=Wed Jul 03 08:54:51 CST 2024, time=2024-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2237949, encodeId=d77a223e94955, content=偏重的研究方向：肿瘤 经验分享：请问下，投稿之后需要所有作者确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d539038449, createdName=ms8000000170261507, createdTime=Wed Nov 20 11:08:46 CST 2024, time=2024-11-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2094226, encodeId=6a6e20942265e, content=为什么他们Decision in Process也很长时间啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Mon Oct 17 15:06:43 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2231244, encodeId=0472223124429, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23228777946, createdName=ms4000000258200034, createdTime=Wed Oct 16 19:59:25 CST 2024, time=2024-10-16, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2230114, encodeId=d98a223011450, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3b29401030, createdName=ms6000002046878418, createdTime=Thu Oct 10 10:05:03 CST 2024, time=2024-10-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=568875, encodeId=d75e5688e599, content=请问后面什么情况奔跑在Nature路上的小兽医 2018-06-20 16:18:00 发表: 2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu, beContent=奔跑在Nature路上的小兽医 2018-06-20 16:18:00 发表: 2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73ea1969766, createdName=∠※∠※, createdTime=Sat Mar 30 00:00:00 CST 2019, time=2019-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566871, encodeId=8ccc5668e10f, content=投稿10多天，状态一直在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=406a1737298, createdName=成吉思汗111, createdTime=Sun Feb 17 12:25:00 CST 2019, time=2019-02-17, status=1, ipAttribution=)]

2024-11-20 ms8000000170261507 来自湖北省

偏重的研究方向：肿瘤
经验分享：请问下，投稿之后需要所有作者确认吗？

28 0

[GetPortalCommentsPageByObjectIdResponse(id=2239955, encodeId=634c22399558e, content=这个杂志不建议投，真慢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=faf92276694, createdName=121b8024m37(暂无昵称), createdTime=Fri Nov 29 19:54:09 CST 2024, time=2024-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2149724, encodeId=9c952149e2440, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：生物;药理 经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8e7d2228833, createdName=Mr.Curiosity, createdTime=Tue Jul 25 11:41:51 CST 2023, time=2023-07-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2243080, encodeId=3029224308039, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：请问需要流式的原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ece5698328, createdName=ms2000001785238562, createdTime=Tue Dec 17 10:34:35 CST 2024, time=2024-12-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2212910, encodeId=824c2212910f4, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：自从收到预接受文件满心欢喜。修回格式已经20天了，还没有收到正式接收的邮件，心里忐忑不安。。。。有没有朋友遇到同样情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=ed509121182, createdName=科研~菜鸟, createdTime=Wed Jul 03 08:54:51 CST 2024, time=2024-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2237949, encodeId=d77a223e94955, content=偏重的研究方向：肿瘤 经验分享：请问下，投稿之后需要所有作者确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d539038449, createdName=ms8000000170261507, createdTime=Wed Nov 20 11:08:46 CST 2024, time=2024-11-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2094226, encodeId=6a6e20942265e, content=为什么他们Decision in Process也很长时间啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Mon Oct 17 15:06:43 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2231244, encodeId=0472223124429, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23228777946, createdName=ms4000000258200034, createdTime=Wed Oct 16 19:59:25 CST 2024, time=2024-10-16, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2230114, encodeId=d98a223011450, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3b29401030, createdName=ms6000002046878418, createdTime=Thu Oct 10 10:05:03 CST 2024, time=2024-10-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=568875, encodeId=d75e5688e599, content=请问后面什么情况奔跑在Nature路上的小兽医 2018-06-20 16:18:00 发表: 2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu, beContent=奔跑在Nature路上的小兽医 2018-06-20 16:18:00 发表: 2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73ea1969766, createdName=∠※∠※, createdTime=Sat Mar 30 00:00:00 CST 2019, time=2019-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566871, encodeId=8ccc5668e10f, content=投稿10多天，状态一直在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=406a1737298, createdName=成吉思汗111, createdTime=Sun Feb 17 12:25:00 CST 2019, time=2019-02-17, status=1, ipAttribution=)]

2022-10-17 ms9000000615443695

为什么他们Decision in Process也很长时间啊！！！

158 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2239955, encodeId=634c22399558e, content=这个杂志不建议投，真慢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=faf92276694, createdName=121b8024m37(暂无昵称), createdTime=Fri Nov 29 19:54:09 CST 2024, time=2024-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2149724, encodeId=9c952149e2440, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：生物;药理 经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8e7d2228833, createdName=Mr.Curiosity, createdTime=Tue Jul 25 11:41:51 CST 2023, time=2023-07-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2243080, encodeId=3029224308039, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：请问需要流式的原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ece5698328, createdName=ms2000001785238562, createdTime=Tue Dec 17 10:34:35 CST 2024, time=2024-12-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2212910, encodeId=824c2212910f4, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：自从收到预接受文件满心欢喜。修回格式已经20天了，还没有收到正式接收的邮件，心里忐忑不安。。。。有没有朋友遇到同样情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=ed509121182, createdName=科研~菜鸟, createdTime=Wed Jul 03 08:54:51 CST 2024, time=2024-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2237949, encodeId=d77a223e94955, content=偏重的研究方向：肿瘤 经验分享：请问下，投稿之后需要所有作者确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d539038449, createdName=ms8000000170261507, createdTime=Wed Nov 20 11:08:46 CST 2024, time=2024-11-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2094226, encodeId=6a6e20942265e, content=为什么他们Decision in Process也很长时间啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Mon Oct 17 15:06:43 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2231244, encodeId=0472223124429, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23228777946, createdName=ms4000000258200034, createdTime=Wed Oct 16 19:59:25 CST 2024, time=2024-10-16, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2230114, encodeId=d98a223011450, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3b29401030, createdName=ms6000002046878418, createdTime=Thu Oct 10 10:05:03 CST 2024, time=2024-10-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=568875, encodeId=d75e5688e599, content=请问后面什么情况奔跑在Nature路上的小兽医 2018-06-20 16:18:00 发表: 2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu, beContent=奔跑在Nature路上的小兽医 2018-06-20 16:18:00 发表: 2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73ea1969766, createdName=∠※∠※, createdTime=Sat Mar 30 00:00:00 CST 2019, time=2019-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566871, encodeId=8ccc5668e10f, content=投稿10多天，状态一直在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=406a1737298, createdName=成吉思汗111, createdTime=Sun Feb 17 12:25:00 CST 2019, time=2019-02-17, status=1, ipAttribution=)]

2024-10-16 ms4000000258200034 来自吉林省

无

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2239955, encodeId=634c22399558e, content=这个杂志不建议投，真慢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=faf92276694, createdName=121b8024m37(暂无昵称), createdTime=Fri Nov 29 19:54:09 CST 2024, time=2024-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2149724, encodeId=9c952149e2440, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：生物;药理 经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8e7d2228833, createdName=Mr.Curiosity, createdTime=Tue Jul 25 11:41:51 CST 2023, time=2023-07-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2243080, encodeId=3029224308039, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：请问需要流式的原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ece5698328, createdName=ms2000001785238562, createdTime=Tue Dec 17 10:34:35 CST 2024, time=2024-12-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2212910, encodeId=824c2212910f4, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：自从收到预接受文件满心欢喜。修回格式已经20天了，还没有收到正式接收的邮件，心里忐忑不安。。。。有没有朋友遇到同样情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=ed509121182, createdName=科研~菜鸟, createdTime=Wed Jul 03 08:54:51 CST 2024, time=2024-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2237949, encodeId=d77a223e94955, content=偏重的研究方向：肿瘤 经验分享：请问下，投稿之后需要所有作者确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d539038449, createdName=ms8000000170261507, createdTime=Wed Nov 20 11:08:46 CST 2024, time=2024-11-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2094226, encodeId=6a6e20942265e, content=为什么他们Decision in Process也很长时间啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Mon Oct 17 15:06:43 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2231244, encodeId=0472223124429, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23228777946, createdName=ms4000000258200034, createdTime=Wed Oct 16 19:59:25 CST 2024, time=2024-10-16, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2230114, encodeId=d98a223011450, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3b29401030, createdName=ms6000002046878418, createdTime=Thu Oct 10 10:05:03 CST 2024, time=2024-10-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=568875, encodeId=d75e5688e599, content=请问后面什么情况奔跑在Nature路上的小兽医 2018-06-20 16:18:00 发表: 2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu, beContent=奔跑在Nature路上的小兽医 2018-06-20 16:18:00 发表: 2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73ea1969766, createdName=∠※∠※, createdTime=Sat Mar 30 00:00:00 CST 2019, time=2019-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566871, encodeId=8ccc5668e10f, content=投稿10多天，状态一直在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=406a1737298, createdName=成吉思汗111, createdTime=Sun Feb 17 12:25:00 CST 2019, time=2019-02-17, status=1, ipAttribution=)]

2024-10-10 ms6000002046878418 来自辽宁省

审稿速度:24.0 | 投稿命中率:5.0
经验分享：好慢

38 0

[GetPortalCommentsPageByObjectIdResponse(id=2239955, encodeId=634c22399558e, content=这个杂志不建议投，真慢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=faf92276694, createdName=121b8024m37(暂无昵称), createdTime=Fri Nov 29 19:54:09 CST 2024, time=2024-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2149724, encodeId=9c952149e2440, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：生物;药理 经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8e7d2228833, createdName=Mr.Curiosity, createdTime=Tue Jul 25 11:41:51 CST 2023, time=2023-07-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2243080, encodeId=3029224308039, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：请问需要流式的原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ece5698328, createdName=ms2000001785238562, createdTime=Tue Dec 17 10:34:35 CST 2024, time=2024-12-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2212910, encodeId=824c2212910f4, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：自从收到预接受文件满心欢喜。修回格式已经20天了，还没有收到正式接收的邮件，心里忐忑不安。。。。有没有朋友遇到同样情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=ed509121182, createdName=科研~菜鸟, createdTime=Wed Jul 03 08:54:51 CST 2024, time=2024-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2237949, encodeId=d77a223e94955, content=偏重的研究方向：肿瘤 经验分享：请问下，投稿之后需要所有作者确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d539038449, createdName=ms8000000170261507, createdTime=Wed Nov 20 11:08:46 CST 2024, time=2024-11-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2094226, encodeId=6a6e20942265e, content=为什么他们Decision in Process也很长时间啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Mon Oct 17 15:06:43 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2231244, encodeId=0472223124429, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23228777946, createdName=ms4000000258200034, createdTime=Wed Oct 16 19:59:25 CST 2024, time=2024-10-16, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2230114, encodeId=d98a223011450, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3b29401030, createdName=ms6000002046878418, createdTime=Thu Oct 10 10:05:03 CST 2024, time=2024-10-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=568875, encodeId=d75e5688e599, content=请问后面什么情况奔跑在Nature路上的小兽医 2018-06-20 16:18:00 发表: 2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu, beContent=奔跑在Nature路上的小兽医 2018-06-20 16:18:00 发表: 2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73ea1969766, createdName=∠※∠※, createdTime=Sat Mar 30 00:00:00 CST 2019, time=2019-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566871, encodeId=8ccc5668e10f, content=投稿10多天，状态一直在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=406a1737298, createdName=成吉思汗111, createdTime=Sun Feb 17 12:25:00 CST 2019, time=2019-02-17, status=1, ipAttribution=)]

2019-03-30 ∠※∠※

请问后面什么情况奔跑在Nature路上的小兽医 2018-06-20 16:18:00 发表:
2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu

奔跑在Nature路上的小兽医 2018-06-20 16:18:00 发表: 2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu

150 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2239955, encodeId=634c22399558e, content=这个杂志不建议投，真慢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=faf92276694, createdName=121b8024m37(暂无昵称), createdTime=Fri Nov 29 19:54:09 CST 2024, time=2024-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2149724, encodeId=9c952149e2440, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：生物;药理 经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8e7d2228833, createdName=Mr.Curiosity, createdTime=Tue Jul 25 11:41:51 CST 2023, time=2023-07-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2243080, encodeId=3029224308039, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：请问需要流式的原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ece5698328, createdName=ms2000001785238562, createdTime=Tue Dec 17 10:34:35 CST 2024, time=2024-12-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2212910, encodeId=824c2212910f4, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：自从收到预接受文件满心欢喜。修回格式已经20天了，还没有收到正式接收的邮件，心里忐忑不安。。。。有没有朋友遇到同样情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=ed509121182, createdName=科研~菜鸟, createdTime=Wed Jul 03 08:54:51 CST 2024, time=2024-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2237949, encodeId=d77a223e94955, content=偏重的研究方向：肿瘤 经验分享：请问下，投稿之后需要所有作者确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d539038449, createdName=ms8000000170261507, createdTime=Wed Nov 20 11:08:46 CST 2024, time=2024-11-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2094226, encodeId=6a6e20942265e, content=为什么他们Decision in Process也很长时间啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Mon Oct 17 15:06:43 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2231244, encodeId=0472223124429, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23228777946, createdName=ms4000000258200034, createdTime=Wed Oct 16 19:59:25 CST 2024, time=2024-10-16, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2230114, encodeId=d98a223011450, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3b29401030, createdName=ms6000002046878418, createdTime=Thu Oct 10 10:05:03 CST 2024, time=2024-10-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=568875, encodeId=d75e5688e599, content=请问后面什么情况奔跑在Nature路上的小兽医 2018-06-20 16:18:00 发表: 2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu, beContent=奔跑在Nature路上的小兽医 2018-06-20 16:18:00 发表: 2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73ea1969766, createdName=∠※∠※, createdTime=Sat Mar 30 00:00:00 CST 2019, time=2019-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566871, encodeId=8ccc5668e10f, content=投稿10多天，状态一直在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=406a1737298, createdName=成吉思汗111, createdTime=Sun Feb 17 12:25:00 CST 2019, time=2019-02-17, status=1, ipAttribution=)]

2019-02-17 成吉思汗111

投稿10多天，状态一直在with editor

192 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务